Literature DB >> 1756877

The value of duplex scanning with venous occlusion in the preoperative prediction of femoro-distal vein bypass graft diameter.

A H Davies1, T R Magee, D R Jones, J K Hayward, R N Baird, M Horrocks.   

Abstract

The diameter of the long saphenous vein has been shown to affect the outcome of femoro-distal bypass. Many surgeons regard a vein with a diameter of less than 3 mm as being unsuitable. The long saphenous vein was studied in 35 patients undergoing femoro-distal bypass. Diameter measurements of the vein were performed using an ATL duplex scanner at the groin, mid-thigh and knee. Measurements were performed preoperatively both at rest and with a venous occlusion cuff to dilate the vein, and subsequently at 7 days and 2 months after implantation. The mean diameter of the vein at the mid-thigh was 4.1 mm non-dilated, 5.1 mm with occlusion, 5.0 mm 7 days postoperatively and 5.2 mm at 2 months (ANOVA, p less than 0.05). The mean diameter of the vein at the knee was 3.9 mm non-dilated, 4.8 mm with occlusion, 4.8 mm at 7 days and 4.9 mm at 2 months after operation (ANOVA, p less than 0.025). In all five patients whose preoperative resting vein diameter at the knee or mid-thigh was less than 3 mm, preoperative dilatation occurred, such that the diameter became greater than 3 mm. These results suggest that by using a technique of venous occlusion at the time of pre-operative vein mapping, the functional diameter of the vein can be predicted and vein utilisation may be increased.

Entities:  

Mesh:

Year:  1991        PMID: 1756877     DOI: 10.1016/s0950-821x(05)80897-7

Source DB:  PubMed          Journal:  Eur J Vasc Surg        ISSN: 0950-821X


  2 in total

1.  Vein factors that affect the outcome of femorodistal bypass.

Authors:  A H Davies
Journal:  Ann R Coll Surg Engl       Date:  1995-01       Impact factor: 1.891

2.  Doppler ultrasound venous mapping of the lower limbs.

Authors:  Aldo Innocente Galeandro; Giovanni Quistelli; Pietro Scicchitano; Michele Gesualdo; Annapaola Zito; Paola Caputo; Rosa Carbonara; Giuseppe Galgano; Francesco Ciciarello; Sandro Mandolesi; Claude Franceschi; Marco Matteo Ciccone
Journal:  Vasc Health Risk Manag       Date:  2012-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.